Generics 28

Innovative

Biosimilars

Medical devices

Nutraceuticals

Filters

Bimatoprost manufacturers

28 products found

Filters

Filters

Filters , active

Country of origin : India

Clear all

28 products found

bimatoprost

Ophthalmic solution 0.03 % - 3 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP
Manufacturer #35915

Established in 2007, this family-owned manufacturer specializes in pharmaceutical formulations, offering over 500 products across various dosage forms, including tablets, capsules, dry syrups, ointments, dry injections, and liquid orals. As a CTD dossier owner and manufacturer, it holds WHO-cGMP certification, ensuring compliance with stringent international quality standards. The manufacturer operates advanced production lines with capacities such as 3,600 million tablets, 1,800 million capsules, 240 million liquid injections in ampoules, and 70 million dry powder injections per annum, adhering to rigorous GMP guidelines. As a CTD dossier owner and manufacturer, its products are distributed across multiple countries worldwide.

Manufacturer usually replies in 7 days

bimatoprost + timolol maleate

Eye drops 0.03% + 0.5 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18175
This pharmaceutical company specializes in affordable and innovative medicines across a range of therapy areas, including those focused on pain management, gastrointestinal health, and cardiovascular conditions. They produce over 50 new products annually, offering a variety of dosage forms like tablets, capsules, and syrups. Their manufacturing facilities adhere to WHO-cGMP norms and hold ISO 9001:2015 certifications, ensuring high quality and safety standards. The company boasts a dedicated R&D team with over 100 members, continually developing new formulations to improve patient health. They have established a strong presence in key regions including the EU and North America, exporting their products to over 60 countries.

Manufacturer usually replies in 5 days

bimatoprost

Ophthalmic solution 0.03%

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18175
This pharmaceutical company specializes in affordable and innovative medicines across a range of therapy areas, including those focused on pain management, gastrointestinal health, and cardiovascular conditions. They produce over 50 new products annually, offering a variety of dosage forms like tablets, capsules, and syrups. Their manufacturing facilities adhere to WHO-cGMP norms and hold ISO 9001:2015 certifications, ensuring high quality and safety standards. The company boasts a dedicated R&D team with over 100 members, continually developing new formulations to improve patient health. They have established a strong presence in key regions including the EU and North America, exporting their products to over 60 countries.

Manufacturer usually replies in 5 days

Want to see all 28 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription
Bimatoprost Manufacturers Bimatoprost belongs to a group of drugs called Prostamides, which are physiologically active lipids, like substances that are chemically related to prostaglandins. Bimatoprost is a synthetic structural analog of prostaglandins. Bimatoprost is used for lowering the pressure in the eye by increasing the amount of fluid that is drained from the eyes. It is also used to treat certain types of Glaucoma. As this is not tested in below 18 years of age group, this should not be used for patients under 18 years of age. It is always recommended to consult a physician before taking Bimatoprost as this medication may interact with other drugs or health problems. Manufacturers of Bimatoprost market these drugs under the Brand name of LUMIGAN, LATISEE, CAREPROST, LOWPROST, and INTRAPROST, all these are available as ophthalmic solution 0.01% and 0.03 %, which are administered into the eye as drops. The daily-recommended dosage is one drop in the affected eye once in the evening, which has its effects up to 24 hours. Patients having contact lens have to remove it before the administration and can again reinsert 15 minutes following the administration. Bimatoprost is also used to treat the growth of eyelashes. The approved storage conditions for Bimatoprost is at 2 C – 25 C (36 F – 77 F). Wholesale Price of Bimatoprost Bimatoprost is available in the varied strengths from 3ml to 9ml. In the US region the lowest price for Bimatoprost (Lumigan) 0.01% is $18.64 per ml for 8ml and similarly for 0.03% is $4.75 per ml for 9ml which is strictly available with physician’s prescription only. Bimatoprost - Mechanism of Action Bimatoprost imitates the effects of prostamides especially prostaglandins. As Bimatoprost mimics the effect of prostaglandins, it is believed to decrease the intraocular pressure (IOP) in humans by increasing the outflow of aqueous humor by not affecting the production of aqueous humor. Finding Bimatoprost Manufacturers and Suppliers Finding a trustful partner in our business is one of the biggest challenges and to overcome that challenge and to make one’s work/life easy in finding the trusted manufacturer and supplier of Bimatoprost one can visit the Pipelinepharma website which helps you in finding the trusted manufacturers and suppliers of Bimatoprost. Pipelinepharma, which is a business-to-business (B2B) licensing marketplace for pharmaceutical products that quickly connects the owner with the customers for business development. You can filter the product names in user-friendly and unified search engine by its country, category, therapeutic area, forms, dossier, and its status, regulatory filings, approvals, and more.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible

Want unlimited access to the Pipelinepharma database?

Become a subscriber to unlock:

  • Streamlined product sourcing: access the only CTD dossier pipeline and sourcing platform.

  • Direct connections: communicate directly with CTD dossier owners and manufacturers with no brokerage fees.

  • Higher profitability: compare multiple supplier offers and secure the best commercial terms.

  • Expanded network: view supplier portfolios and stay updated on new products.

  • Value-added product ideas: discover products with lower competition potential.

  • Access to marketing authorizations for sale: find already registered products in your target markets.